📊 MCHPP Key Takeaways
Is MCHPP a Good Investment? Thesis Analysis
Microchip demonstrates strong operational cash generation and solid balance sheet quality with a 2.16x current ratio and manageable 0.82x debt-to-equity leverage. However, severe revenue contraction of 42.3% YoY combined with razor-thin 2.5% net margins and depressed returns on equity (1.3%) signal cyclical headwinds in the semiconductor sector that overshadow operational strengths. The 81.5% net income increase appears anomalous given revenue collapse, suggesting one-time items or significant cost restructuring that requires clarification.
Why Buy MCHPP? Key Strengths
- Strong free cash flow generation of $628.2M (18.5% FCF margin) demonstrates underlying business quality despite cyclical revenue downturn
- Solid liquidity position with 2.16x current ratio and 1.16x quick ratio indicates financial stability and ability to weather sector weakness
- Healthy gross margin of 56.5% provides cushion for operational leverage recovery if demand normalizes
- Manageable leverage at 0.82x debt-to-equity with 2.3x interest coverage maintains financial flexibility
MCHPP Investment Risks to Consider
- Severe revenue decline of 42.3% YoY indicates significant cyclical downturn in semiconductor demand with unclear recovery timeline
- Net margin compression to 2.5% is critically low and leaves minimal room for error or additional cost pressures
- Poor return metrics (ROE 1.3%, ROA 0.6%) suggest capital is not generating adequate returns on deployed assets during this cycle
- Disconnect between net income growth (+81.5%) and revenue collapse (-42.3%) raises concerns about sustainability and reliance on non-recurring items
- Long-term debt of $5.4B represents 82% of stockholders equity, limiting financial flexibility if conditions deteriorate further
Key Metrics to Watch
- Quarterly revenue trend and gross margin recovery as sector cycle inflects
- Operating cash flow sustainability and capital expenditure levels during downturn
- Net margin expansion drivers and extent of one-time items in current earnings
- Debt reduction trajectory and free cash flow deployment priorities
- Industry inventory levels and customer demand indicators for recovery timing
MCHPP Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 2.16x current ratio provides a solid financial cushion.
MCHPP Profitability Ratios
MCHPP vs Technology Sector
How MICROCHIP TECHNOLOGY INC compares to Technology sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is MCHPP Overvalued or Undervalued?
Based on fundamental analysis, MICROCHIP TECHNOLOGY INC shows some fundamental concerns relative to the Technology sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
MCHPP Balance Sheet & Liquidity
MCHPP 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: MICROCHIP TECHNOLOGY INC's revenue has grown significantly by 55% over the 5-year period, indicating strong business expansion. The most recent EPS of $4.02 reflects profitable operations.
MCHPP Growth Metrics (YoY)
MCHPP Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $1.0B | -$18.6M | $0.00 |
| Q2 2026 | $1.1B | -$18.6M | $0.03 |
| Q1 2026 | $1.1B | -$18.6M | $-0.09 |
| Q3 2025 | $1.0B | -$53.6M | $-0.10 |
| Q2 2025 | $1.2B | $78.4M | $0.14 |
| Q1 2025 | $1.2B | $129.3M | $0.24 |
| Q3 2024 | $1.8B | $419.2M | $0.77 |
| Q2 2024 | $2.1B | $507.2M | $0.98 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
MCHPP Capital Allocation
MCHPP SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for MICROCHIP TECHNOLOGY INC (CIK: 0000827054)
📋 Recent SEC Filings
| Date | Form | Document | Action |
|---|---|---|---|
| Mar 4, 2026 | 4 | xslF345X05/wk-form4_1772658848.xml | View → |
| Mar 4, 2026 | 4 | xslF345X05/wk-form4_1772658787.xml | View → |
| Mar 4, 2026 | 4 | xslF345X05/wk-form4_1772658710.xml | View → |
| Mar 4, 2026 | 4 | xslF345X05/wk-form4_1772658632.xml | View → |
| Mar 4, 2026 | 4 | xslF345X05/wk-form4_1772658555.xml | View → |
❓ Frequently Asked Questions about MCHPP
What is the AI rating for MCHPP?
MICROCHIP TECHNOLOGY INC (MCHPP) has an AI rating of HOLD with 62% confidence, based on fundamental analysis of SEC EDGAR filings.
What are MCHPP's key strengths?
Claude: Strong free cash flow generation of $628.2M (18.5% FCF margin) demonstrates underlying business quality despite cyclical revenue downturn. Solid liquidity position with 2.16x current ratio and 1.16x quick ratio indicates financial stability and ability to weather sector weakness.
What are the risks of investing in MCHPP?
Claude: Severe revenue decline of 42.3% YoY indicates significant cyclical downturn in semiconductor demand with unclear recovery timeline. Net margin compression to 2.5% is critically low and leaves minimal room for error or additional cost pressures.
What is MCHPP's revenue and growth?
MICROCHIP TECHNOLOGY INC reported revenue of $3.4B.
Does MCHPP pay dividends?
MICROCHIP TECHNOLOGY INC pays dividends, with $737.4M distributed to shareholders in the trailing twelve months.
Where can I find MCHPP SEC filings?
Official SEC filings for MICROCHIP TECHNOLOGY INC (CIK: 0000827054) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is MCHPP's EPS?
MICROCHIP TECHNOLOGY INC has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is MCHPP a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, MICROCHIP TECHNOLOGY INC has a HOLD rating with 62% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is MCHPP stock overvalued or undervalued?
Valuation metrics for MCHPP: ROE of 1.3% (sector avg: 22%), net margin of 2.5% (sector avg: 18%). Compare these metrics with sector averages to assess valuation.
Should I buy MCHPP stock in 2026?
Our dual AI analysis gives MICROCHIP TECHNOLOGY INC a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is MCHPP's free cash flow?
MICROCHIP TECHNOLOGY INC's operating cash flow is $705.1M, with capital expenditures of $76.9M. FCF margin is 18.5%.
How does MCHPP compare to other Technology stocks?
Vs Technology sector averages: Net margin 2.5% (avg: 18%), ROE 1.3% (avg: 22%), current ratio 2.16 (avg: 2.5).